This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Lek Pharmaceutical and Chemical Company D.d., Lek, Tovarna Farmacevtskih, Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d.. Active years: 1996-2003.
Company Filing History:
1 out of 13 
1 out of 3 
1 out of 9 Years Active: 1996-2003
Title: The Innovations of Mateja Kovacic
Introduction
Mateja Kovacic is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. With a total of 4 patents to his name, Kovacic's work has had a meaningful impact on the industry.
Latest Patents
Among his latest patents is a pharmaceutical suspension formulation comprising amoxycillin clavulanic acid and cellulose. This innovative liquid aqueous pharmaceutical suspension formulation contains amoxycillin trihydrate, potassium clavulanate, and microcrystalline cellulose filler. Another notable patent involves inclusion complexes of racemic ibuproxam and optically active compounds, showcasing his expertise in complex pharmaceutical formulations.
Career Highlights
Kovacic has worked with prominent companies in the pharmaceutical sector, including Lek and Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical formulations.
Collaborations
Throughout his career, Kovacic has collaborated with talented individuals such as Janko Zmitek and Katarina Verhnjak. These partnerships have fostered a creative environment that has led to the development of groundbreaking pharmaceutical solutions.
Conclusion
Mateja Kovacic's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medication formulation and delivery.